Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $319,516 | 71 | 88.5% |
| Travel and Lodging | $19,834 | 53 | 5.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,250 | 3 | 3.4% |
| Food and Beverage | $5,404 | 90 | 1.5% |
| Honoraria | $3,940 | 3 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $151,767 | 109 | $0 (2023) |
| Novo Nordisk Inc | $69,703 | 27 | $0 (2024) |
| Madrigal Pharmaceuticals | $26,106 | 2 | $0 (2024) |
| PFIZER INC. | $20,844 | 11 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $14,108 | 8 | $0 (2020) |
| Merck Sharp & Dohme LLC | $13,173 | 11 | $0 (2022) |
| Bard Peripheral Vascular, Inc. | $13,163 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $11,289 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $8,533 | 3 | $0 (2021) |
| Shire North American Group Inc | $8,170 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44,827 | 12 | Madrigal Pharmaceuticals ($26,106) |
| 2023 | $39,887 | 20 | Novo Nordisk Inc ($20,326) |
| 2022 | $52,696 | 24 | Novo Nordisk Inc ($28,529) |
| 2021 | $49,861 | 15 | Novo Nordisk Inc ($14,985) |
| 2020 | $24,930 | 6 | Intercept Pharmaceuticals, Inc. ($7,800) |
| 2019 | $58,903 | 47 | Gilead Sciences, Inc. ($48,891) |
| 2018 | $34,902 | 38 | Gilead Sciences, Inc. ($26,086) |
| 2017 | $54,937 | 58 | Gilead Sciences Inc ($44,851) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Consulting Fee | Cash or cash equivalent | $25,530.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/12/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Consulting Fee | Cash or cash equivalent | $575.51 | General |
| Category: LIVER DISEASE | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| 09/06/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $3,763.69 | General |
| 09/06/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $1,500.31 | General |
| 07/29/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 06/24/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $325.00 | General |
| 05/16/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| 05/06/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $2,082.50 | General |
| 04/17/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,225.00 | General |
| 02/16/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 01/04/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| 12/08/2023 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,850.00 | General |
| 12/04/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 11/22/2023 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 11/12/2023 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $124.19 | General |
| 11/01/2023 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: ORTHOPEDICS | ||||||
| 10/18/2023 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 10/05/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $8,478.75 | General |
| 10/05/2023 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $432.51 | General |
| 10/05/2023 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $399.20 | General |
| 10/05/2023 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $189.00 | General |
| 10/05/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $57.96 | General |
| 09/09/2023 | Avanos Medical | CORTRAK (Device) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: DIGESTIVE HEALTH | ||||||
| 07/11/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $2,975.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 160 | 206 | $98,844 | $19,932 |
| 2022 | 5 | 112 | 151 | $83,869 | $18,144 |
| 2021 | 4 | 77 | 118 | $55,275 | $13,480 |
| 2020 | 5 | 70 | 112 | $54,754 | $11,013 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 29 | $16,521 | $3,997 | 24.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 52 | $14,968 | $3,518 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 20 | 28 | $15,704 | $3,211 | 20.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 23 | $19,034 | $2,574 | 13.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $9,904 | $1,919 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 18 | $7,602 | $1,802 | 23.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $8,535 | $1,530 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 17 | $6,021 | $1,247 | 20.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 16 | $555.00 | $134.40 | 24.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 27 | 38 | $20,326 | $4,661 | 22.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 44 | $17,624 | $3,806 | 21.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $12,979 | $2,884 | 22.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $17,835 | $2,841 | 15.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 15 | $8,365 | $2,327 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 19 | 20 | $6,740 | $1,623 | 24.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 17 | 31 | $16,099 | $3,927 | 24.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 41 | $15,839 | $3,648 | 23.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 14 | 14 | $10,094 | $2,271 | 22.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 14 | $7,476 | $2,074 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 18 | $5,767 | $1,560 | 27.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 47 | $17,543 | $4,201 | 23.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 18 | 24 | $12,392 | $2,322 | 18.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 12 | $10,944 | $2,088 | 19.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 11 | $8,241 | $1,249 | 15.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 12 | 18 | $5,634 | $1,153 | 20.5% |
About Michael Charlton
Michael Charlton is a Transplant Hepatology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821064692.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Charlton has received a total of $360,944 in payments from pharmaceutical and medical device companies, with $44,827 received in 2024. These payments were reported across 220 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($319,516).
As a Medicare-enrolled provider, Charlton has provided services to 419 Medicare beneficiaries, totaling 587 services with total Medicare billing of $62,568. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Transplant Hepatology
- Location Chicago, IL
- Active Since 02/23/2006
- Last Updated 10/24/2022
- Taxonomy Code 207RT0003X
- Entity Type Individual
- NPI Number 1821064692
Products in Payments
- REZDIFFRA (Drug) $26,106
- Wako HCC Biomarker(s) DCP and AFP-L3 (Device) $1,985
- ADVIA Immunoassay Reagents/Test Kit/Clinical Utilization (Device) $434.10
- ZORTRESS (Drug) $318.82
- XIFIXAN (Drug) $184.78
- OCALIVA (Drug) $166.61
- Cook Medical Endoscopic Ultrasound (Device) $135.03
- GORE CARDIOFORM Septal Occluder (Device) $53.43
- EUFLEXXA (Device) $28.24
- LIVTENCITY (Drug) $22.18
- Stivarga (Drug) $20.42
- CORTRAK (Device) $18.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Transplant Hepatology Doctors in Chicago
Dr. Krystina Johnson, Md, MD
Transplant Hepatology — Payments: $1,996
Maria El Gemayel, Md, MD
Transplant Hepatology — Payments: $33.08
Andrew Aronsohn
Transplant Hepatology — Payments: $23.58
Dr. Nisha Howarth
Transplant Hepatology
Pavithra Parthasarathy, Md, MD
Transplant Hepatology